Science & Medicine

Fred Aslan, Artiva CEO, on Cell Therapy’s Next Wave, RA Trials & Scalable NK Platforms

Biotech 2050 Podcast by Biotech2050 Podcast

Feb 11, 202600:25:06Science & Medicine

Synopsis: At the heart of JPM 2026’s biotech buzz, Alok Tayi sits down with Fred Aslan, CEO of Artiva, to explore how bold platform bets, scalable cell therapies, and autoimmune breakthroughs could reshape medicine. Fred...

About This Episode

Fred Aslan, Artiva CEO, on Cell Therapy’s Next Wave, RA Trials & Scalable NK Platforms is an episode from Biotech 2050 Podcast by Biotech2050 Podcast. Synopsis: At the heart of JPM 2026’s biotech buzz, Alok Tayi sits down with Fred Aslan, C...

Podcast

This episode belongs to Biotech 2050 Podcast.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Feb 11, 2026, 00:25:06 long, audio available.

Fred Aslan, Artiva CEO, on Cell Therapy’s Next Wave, RA Trials & Scalable NK Platforms

About This Episode

Related Episodes